pharmaphorum

APRIL 20, 2021

The Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit is the definitive industry-led forum for drug development in the largest solid tumor indication. The post Non-Small Cell Lung Cancer Drug Development Summit appeared first on. View the event guide now for more details!

Drug Development 52

Drug Development Medical Schools Immunity Immunization 52

FDA Law Blog: Biosimilars

MARCH 13, 2023

Bauer, Senior Regulatory Drug Expert & James E. Valentine — Incorporating patient and caregiver experiences into every phase of drug development has become increasingly prioritized during both development and review ( see, e.g. , previous coverage here ). By Larry J. His eczema cleared up completely.

Drug Development 98

Drug Development Immunity Immunization 98

pharmaphorum

OCTOBER 12, 2020

In addition to the agenda, there will be two pre-conference interactive workshops on: Workshop A – 08.30 – 12.30 on How to Develop Physiologically Relevant Immune Competent Models in MPS, led by Pelin Candarlioglu, Investigator – Bioengineer/Cell Biologist, GSK. Workshop B – 13.30 – 17.30

Immunity 52

Immunity Immunization Drug Development 52